Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
4.020
-0.520 (-11.45%)
At close: Nov 2, 2026, 4:00 PM EST
4.050
+0.030 (0.75%)
After-hours: Nov 2, 2026, 7:01 PM EST
Quoin Pharmaceuticals Employees
As of December 31, 2025, Quoin Pharmaceuticals had 6 total employees, including 4 full-time and 2 part-time employees. The number of employees increased by 1 or 20.00% compared to the previous year. That makes Quoin Pharmaceuticals the 41,570th largest employer in the world and 6,474th in the United States.
Employees
6
Change (1Y)
1
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$3,110,886
Market Cap
19.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | 1 | 20.00% | 4 | 2 |
| Dec 31, 2024 | 5 | 1 | 25.00% | 3 | 2 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2021 | 4 | 2 | 100.00% | 4 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Evaxion | 46 |
| Kyntra Bio | 34 |
| Quantum BioPharma | 17 |
| Atossa Therapeutics | 16 |
| CervoMed | 15 |
| Cocrystal Pharma | 10 |
| Akari Therapeutics, | 6 |
QNRX News
- 4 days ago - Quoin Pharmaceuticals to Announce Corporate Update and Third Quarter 2026 Financial Results on Thursday, November 5, 2026 - GlobeNewsWire
- 5 days ago - Quoin Pharmaceuticals Registration statement: Registration filing - Filings
- 5 days ago - Quoin Pharmaceuticals files $150M mixed securities shelf - TheFly
- 13 days ago - Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy - GlobeNewsWire
- 14 days ago - Quoin Pharmaceuticals initiated with a Buy at Canaccord - TheFly
- 19 days ago - Quoin’s QRX003 granted Orphan Drug Designation in Europe - TheFly
- 19 days ago - Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome - GlobeNewsWire
- 21 days ago - Quoin Pharmaceuticals initiated with a Buy at BTIG - TheFly